表紙
市場調查報告書

可攜式醫療設備的全球市場分析、預測

Global Ambulatory Device Market: Focus on Products, Applications, End Users, Country-wise Analysis, Industry Insights, and Competitive Landscape - Analysis and Forecast, 2018-2028

出版商 BIS Research Inc. 商品編碼 686999
出版日期 內容資訊 英文 289 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
可攜式醫療設備的全球市場分析、預測 Global Ambulatory Device Market: Focus on Products, Applications, End Users, Country-wise Analysis, Industry Insights, and Competitive Landscape - Analysis and Forecast, 2018-2028
出版日期: 2018年08月27日內容資訊: 英文 289 Pages
簡介

全球可攜式醫療設備市場,預計2028年達到175億5000萬美元。由於各種可攜式醫療設備的技術進步和需求增加,這個市場預計急速擴大。

本報告提供全球可攜式醫療設備市場相關調查,等近幾年趨勢,法規必要條件,及技術進步的市場上各種影響要素分析,產品、用途、終端用戶、地區等各市場區隔的分析與預測,主要企業簡介等資訊。

第1章 市場概要

  • 可攜式醫療設備的分類
  • 可攜式醫療設備的優點
  • 可攜式醫療設備的技術進步
  • 可攜式醫療設備:關心領域
  • 可攜式醫療設備:未來的潛在性
  • 全球可攜式醫療設備市場情況
  • 市場規模計算的前提條件、限制事項

第2章 市場動態

  • 影響分析
  • 市場成長的促進因素
  • 市場成長的阻礙要素
  • 市場機會

第3章 競爭考察

  • 主要市場發展、策略
  • 市場佔有率分析
  • 產業的魅力

第4章 產業考察

  • 簡介
  • 專利分析
  • 法律上的必要條件、規定
  • 法規團體

第5章 全球可攜式醫療設備市場:各產品

  • 概要
  • 監測設備
  • 輸液系統
  • 錄音機
  • 其他

第6章 全球可攜式醫療設備市場:各用途

  • 概要
  • 心電圖監控
  • 藥物輸送
  • 血壓監測
  • 血糖監測系統
  • EEG監測
  • 其他

第7章 全球可攜式醫療設備市場:各終端用戶

  • 概要
  • 醫院
  • 通門診外科中心 (ASC)、門診病人診療所
  • 其他

第8章 全球可攜式醫療設備市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲
  • 其他 (RoW)

第9章 企業簡介

第10章 調查範圍、調查手法

第11章 附錄

目錄
Product Code: BH064A

The global ambulatory device market is expected to reach $17.55 billion by 2028.With the increasing demand for the technological advancements across various segments of the ambulatory devices, the ambulatory device market is expected to witness rapid growth in the future.

The medical device industry is focused on the development of advanced ambulatory devices using telemedicine technology for the better outpatient care. The increasing prevalence of chronic disorders and development of the healthcare infrastructure are promoting the growth of the ambulatory devices for better treatment and improved quality of life of patients.

The ambulatory devices include monitoring devices, infusion systems, recorders, and other products to monitor and record the patient's vital signs and examine the obtained results. Currently, ambulatory devices are considered a valuable tool for the outpatients in hospitals, ambulatory surgical centers, and outpatient clinics to provide cost-effective and highly efficient diagnosis and treatment. Moreover, advancements in ambulatory devices reduce turn-around time and complexity of diagnosis with continuous patient monitoring. The telemedicine technology provides several opportunities to develop the precise and targeted treatment for various chronic disorders. The medical device industry is witnessing the growth of ambulatory devices developed using telemedicine technology. Several medical device companies are now indulging in the research and development of such telemedicine-based ambulatory products. Furthermore, the advent of e-health technologies in the medical device industry has enabled the companies to target the root cause of chronic diseases with continuous patient monitoring and provide personal digital assistance to remain competitive in the market.

The purpose of this study is to gain a holistic view of the ambulatory device market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market. The scope of this report constitutes a detailed study of the products associated with the global ambulatory device market, across different regions. The market has been segmented into ‘products,' ‘applications,' ‘end users,' and ‘regions.' The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

This research report aims at answering various aspects of the global ambulatory device market with the help of the key factors driving the market, restraints, and challenges that can inhibit the overall market growth and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities, and challenges) and industry analysis as well.

The research study highlights the factors governing the industry attractiveness with Porter's Five Forces for a comprehensive understanding of the global ambulatory device market. Moreover, the study includes detailed product mapping with further sub-segmentation in various countries, and in each sub-segment, the key market trends, list of the key companies, and the key strategies and developments have also been discussed.

The answers to the following key questions can be derived from this report:

  • How did the ambulatory device market evolve, and what is its scope in the future?
  • What are the major market drivers, challenges, and opportunities in the global ambulatory device market?
  • What are the key developmental strategies that are implemented by the key players to sustain in this market?
  • How will the influencing factors affect the industry attractiveness?
  • How are the ambulatory devices utilized with e-health technologies?
  • How will the reimbursement policies by various government organizations affect the global ambulatory device market?
  • What was the market size of the leading segments and sub-segments of the global ambulatory device market in 2017?
  • How will the industry evolve during the forecast period 2018-2028?
  • What will be the growth rate of the ambulatory devices during the forecast period?
  • How will each segment of the global ambulatory device market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2028?
  • Which product, application, and end user segments are expected to register the highest CAGR for the ambulatory device market?
  • What are the major benefits of the implementation of ambulatory devices in different fields of applications including drug delivery, ECG monitoring, blood pressure monitoring, EEG monitoring, and blood glucose monitoring?
  • What is the market size of ambulatory devices in different countries of the world?
  • Which geographical region will contribute to the highest sales of ambulatory devices?
  • Who are the key players in the ambulatory device market, and what are their contributions?

The key players who have been contributing significantly to the ambulatory device market include Abbott Laboratories, Baxter International Inc., Becton, Dickinson and Company, BioTelemetry, Inc., Boston Scientific Corporation, Cadwell Industries, Inc., CamNtech Ltd., Cardiovascular Systems, Inc., Compumedics Limited, General Electric Company, Halma plc, Hill Rom Holdings, Inc., iRhythm Technologies, Inc., Natus Medical Incorporated, OSI Systems, Inc., Siemens AG, Smiths Group plc, and Vaso Corporation, among others.

Table of Contents

Executive Summary

1. Market Overview

  • 1.1. Classification of Ambulatory Devices
  • 1.2. Advantages of Ambulatory Devices
  • 1.3. Technological Advancements of Ambulatory Devices
  • 1.4. Ambulatory Devices: Areas of Interest
  • 1.5. Ambulatory Devices: Future Potential
  • 1.6. Global Ambulatory Device Market Scenario
  • 1.7. Assumptions and Limitations for Market Size Calculations

2. Market Dynamics

  • 2.1. Impact Analysis
  • 2.2. Market Drivers
    • 2.2.1. Increased Reimbursement Policies
    • 2.2.2. Rising Geriatric Population
    • 2.2.3. Increased Prevalence of Chronic Diseases
    • 2.2.4. Increased Awareness and Adoption of Telemedicine
    • 2.2.5. Increased Awareness about Ambulatory Surgeries
  • 2.3. Market Restraints
    • 2.3.1. Strict Legal Requirements and Regulations
    • 2.3.2. Data Security
  • 2.4. Market Opportunities
    • 2.4.1. Device Connectivity
    • 2.4.2. Increased Storage

3. Competitive Insights

  • 3.1. Key Strategies and Developments
    • 3.1.1. Product Launches and Enhancements
    • 3.1.2. Joint Ventures, Partnerships, and Collaborations
    • 3.1.3. Mergers and Acquisitions
    • 3.1.4. Business Expansions, Awards, Recognitions, Certifications and Others
  • 3.2. Market Share Analysis
  • 3.3. Industry Attractiveness
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Bargaining Power of Buyer
    • 3.3.3. Threat of New Entrants
    • 3.3.4. Threat of Substitute Products
    • 3.3.5. Intensity of Competitive Rivalry

4. Industry Insights

  • 4.1. Introduction
  • 4.2. Patent Analysis
  • 4.3. Legal Requirements and Regulations
    • 4.3.1. Role of the FDA
    • 4.3.2. Legislative Requirements
  • 4.4. Regulatory Bodies

5. Global Ambulatory Device Market (by Products)

  • 5.1. Overview
  • 5.2. Monitoring Devices
  • 5.3. Infusion Systems
  • 5.4. Recorders
  • 5.5. Others

6. Global Ambulatory Device Market (by Applications)

  • 6.1. Overview
  • 6.2. ECG Monitoring
  • 6.3. Drug Delivery
  • 6.4. Blood Pressure Monitoring
  • 6.5. Blood Glucose Monitoring
  • 6.6. EEG Monitoring
  • 6.7. Others

7. Global Ambulatory Device Market (by End Users)

  • 7.1. Overview
  • 7.2. Hospitals
  • 7.3. Ambulatory Surgical Centers and Outpatient Clinics
  • 7.4. Others

8. Global Ambulatory Device Market (by Regions)

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. The U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. The U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. The Netherlands
    • 8.3.7. Switzerland
    • 8.3.8. Belgium
    • 8.3.9. Sweden
    • 8.3.10. Austria
    • 8.3.11. Rest-of-Europe
  • 8.4. Asia-Pacific
    • 8.4.1. Australia
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Japan
    • 8.4.5. South Korea
    • 8.4.6. Rest-of-Asia-Pacific
  • 8.5. Latin America
    • 8.5.1. Brazil
    • 8.5.2. Mexico
    • 8.5.3. Argentina
    • 8.5.4. Rest-of-Latin America
  • 8.6. Middle East and Africa
    • 8.6.1. South Africa
    • 8.6.2. Saudi Arabia
    • 8.6.3. United Arab Emirates (U.A.E.)
    • 8.6.4. Rest-of-Middle East and Africa
  • 8.7. Rest-of-the-World

9. Company Profiles

  • 9.1. Overview
  • 9.2. Abbott Laboratories
    • 9.2.1. Company Overview
    • 9.2.2. Overall Product Portfolio
      • 9.2.2.1. Ambulatory Device market Product Offering
    • 9.2.3. Financials
      • 9.2.3.1. Financial Summary
    • 9.2.4. Global Presence
    • 9.2.5. Recent Developments
    • 9.2.6. SWOT Analysis
  • 9.3. Baxter International Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Overall Product Portfolio
      • 9.3.2.1. Ambulatory Device market Product Offering
    • 9.3.3. Financials
      • 9.3.3.1. Financial Summary
    • 9.3.4. Global Presence
    • 9.3.5. Recent Developments
    • 9.3.6. SWOT Analysis
  • 9.4. Becton, Dickinson and Company
    • 9.4.1. Company Overview
    • 9.4.2. Overall Product Portfolio
      • 9.4.2.1. Ambulatory Device market Product Offering
    • 9.4.3. Financials
      • 9.4.3.1. Financial Summary
    • 9.4.4. Global Presence
    • 9.4.5. Recent Developments
    • 9.4.6. SWOT Analysis
  • 9.5. BioTelemetry, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Overall Product Portfolio
      • 9.5.2.1. Ambulatory Device market Product Offering
    • 9.5.3. Financials
      • 9.5.3.1. Financial Summary
    • 9.5.4. Recent Developments
    • 9.5.5. SWOT Analysis
  • 9.6. Boston Scientific Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Overall Product Portfolio
      • 9.6.2.1. Ambulatory Device market Product Offering
    • 9.6.3. Financials
      • 9.6.3.1. Financial Summary
    • 9.6.4. Global Presence
    • 9.6.5. Recent Developments
    • 9.6.6. SWOT Analysis
  • 9.7. Cadwell Industries, Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Overall Product Portfolio
      • 9.7.2.1. Ambulatory Device market Product Offering
    • 9.7.3. SWOT Analysis
  • 9.8. CamNtech Ltd.
    • 9.8.1. Company Overview
    • 9.8.2. Overall Product Portfolio
      • 9.8.2.1. Ambulatory Device market Product Offering
    • 9.8.3. Recent Developments
    • 9.8.4. SWOT Analysis
  • 9.9. Cardiovascular Systems, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Overall Product Portfolio
      • 9.9.2.1. Ambulatory Device market Product Offering
    • 9.9.3. Financials
      • 9.9.3.1. Financial Summary
    • 9.9.4. Recent Developments
    • 9.9.5. SWOT Analysis
  • 9.10. Compumedics Limited
    • 9.10.1. Company Overview
    • 9.10.2. Overall Product Portfolio
      • 9.10.2.1. Ambulatory Device market Product Offering
    • 9.10.3. Financials
      • 9.10.3.1. Financial Summary
    • 9.10.4. Global Presence
    • 9.10.5. Recent Development
    • 9.10.6. SWOT Analysis
  • 9.11. Dimetek Digital Medical Technologies, Ltd.
    • 9.11.1. Company Overview
    • 9.11.2. Overall Product Portfolio
      • 9.11.2.1. Ambulatory Device market Product Offering
    • 9.11.3. SWOT Analysis
  • 9.12. General Electric Company
    • 9.12.1. Company Overview
    • 9.12.2. Overall Product Portfolio
      • 9.12.2.1. Ambulatory Device market Product Offering
    • 9.12.3. Financials
      • 9.12.3.1. Financial Summary
    • 9.12.4. SWOT Analysis
  • 9.13. SunTech Medical, Inc. (Subsidiary of Halma plc)
    • 9.13.1. Company Overview
  • 9.14. Halma plc (Parent Company)
    • 9.14.1. Company Overview
    • 9.14.2. Overall Product Portfolio
      • 9.14.2.1. Ambulatory Device market Product Offering
    • 9.14.3. Financials
      • 9.14.3.1. Financial Summary
    • 9.14.4. Recent Developments
    • 9.14.5. SWOT Analysis
  • 9.15. Welch Allyn, Inc. (Subsidiary of Hill-Rom Holdings, Inc.)
    • 9.15.1. Company Overview
  • 9.16. Mortara Instruments, Inc. (Subsidiary of Hill-Rom Holdings, Inc.)
    • 9.16.1. Company Overview
  • 9.17. Hill Rom Holdings, Inc. (Parent Company)
    • 9.17.1. Company Overview
    • 9.17.2. Overall Product Portfolio
      • 9.17.2.1. Ambulatory Device market Product Offering
    • 9.17.3. Financials
      • 9.17.3.1. Financial Summary
    • 9.17.4. Global Presence
    • 9.17.5. Recent Developments
    • 9.17.6. SWOT Analysis
  • 9.18. iRhythm Technologies, Inc.
    • 9.18.1. Company Overview
    • 9.18.2. Overall Product Portfolio
      • 9.18.2.1. Ambulatory Device market Product Offering
    • 9.18.3. Financials
      • 9.18.3.1. Financial Summary
    • 9.18.4. Global Presence
    • 9.18.5. Recent Developments
    • 9.18.6. SWOT Analysis
  • 9.19. Mediblu Medical LLC
    • 9.19.1. Company Overview
    • 9.19.2. Overall Product Portfolio
      • 9.19.2.1. Ambulatory Device market Product Offering
    • 9.19.3. SWOT Analysis
  • 9.20. Meditech Ltd.
    • 9.20.1. Company Overview
    • 9.20.2. Overall Product Portfolio
      • 9.20.2.1. Ambulatory Device market Product Offering
    • 9.20.3. Recent Developments
    • 9.20.4. SWOT Analysis
  • 9.21. Micrel Medical Devices SA
    • 9.21.1. Company Overview
    • 9.21.2. Overall Product Portfolio
      • 9.21.2.1. Ambulatory Device market Product Offering
    • 9.21.3. Recent Developments
    • 9.21.4. SWOT Analysis
  • 9.22. Natus Medical Incorporated
    • 9.22.1. Company Overview
    • 9.22.2. Overall Product Portfolio
      • 9.22.2.1. Ambulatory Device market Product Offering
    • 9.22.3. Financials
      • 9.22.3.1. Financial Summary
    • 9.22.4. Global Presence
    • 9.22.5. Recent Developments
    • 9.22.6. SWOT Analysis
  • 9.23. Spacelabs Healthcare (Subsidiary of OSI Systems, Inc.)
    • 9.23.1. Company Overview
  • 9.24. OSI Systems, Inc. (Parent Company)
    • 9.24.1. Company Overview
    • 9.24.2. Overall Product Portfolio
      • 9.24.2.1. Ambulatory Device market Product Offering
    • 9.24.3. Financials
      • 9.24.3.1. Financial Summary
    • 9.24.4. Global Presence
    • 9.24.5. Recent Developments
    • 9.24.6. SWOT Analysis
  • 9.25. Siemens AG
    • 9.25.1. Company Overview
    • 9.25.2. Overall Product Portfolio
      • 9.25.2.1. Ambulatory Device market Product Offering
    • 9.25.3. Financials
      • 9.25.3.1. Financial Summary
    • 9.25.4. Global Presence
    • 9.25.5. SWOT Analysis
  • 9.26. Smiths Group plc
    • 9.26.1. Company Overview
    • 9.26.2. Overall Product Portfolio
      • 9.26.2.1. Ambulatory Device market Product Offering
    • 9.26.3. Financials
      • 9.26.3.1. Financial Summary
    • 9.26.4. Global Presence
    • 9.26.5. Recent Developments
    • 9.26.6. SWOT Analysis
  • 9.27. Vaso Corporation
    • 9.27.1. Company Overview
    • 9.27.2. Overall Product Portfolio
      • 9.27.2.1. Ambulatory Device market Product Offering
    • 9.27.3. Financials
      • 9.27.3.1. Financial Summary
    • 9.27.4. Global Presence
    • 9.27.5. Recent Developments
    • 9.27.6. SWOT Analysis

10. Research Scope and Methodology

  • 10.1. Report Scope
  • 10.2. Ambulatory Device market: Research Methodology

List of Tables

  • Table 1: Global Ambulatory Device Market, 2017 and 2028
  • Table 2.1: Impact Analysis
  • Table 2.2: Percentage of Total Regional Population Aged 65 years and Above: 2015 and 2030
  • Table 4.1: List of Regulatory Bodies Across the World
  • Table 8.1: Global Ambulatory Device Market (by Regions), 2017-2028
  • Table 8.2: Europe: Ambulatory Device market (by Country), 2017-2028
  • Table 9.1: Abbott Laboratories: Product Launches and Enhancements
  • Table 9.2: Abbott Laboratories: Product Approvals
  • Table 9.3: Abbott Laboratories: Acquisition and Collaboration
  • Table 9.4: Baxter International Inc.: Product Approval
  • Table 9.5: Becton, Dickinson and Company: Product Launches
  • Table 9.6: Becton, Dickinson and Company: Product Approval
  • Table 9.7: Becton, Dickinson and Company: Business Expansion
  • Table 9.8: Becton, Dickinson and Company: Recognitions, Awards, and Certifications
  • Table 9.9: Becton, Dickinson and Company: Acquisitions and Collaborations
  • Table 9.10: BioTelemetry, Inc.: Acquisition and Agreement
  • Table 9.11: Boston Scientific Corporation: Acquisition
  • Table 9.12: CamNtech Ltd.: Business Expansions and Product Approvals
  • Table 9.13: Cardiovascular Systems, Inc.: Product Approvals
  • Table 9.14: Cardiovascular Systems, Inc.: Recognition
  • Table 9.15: Cardiovascular Systems, Inc.: Business Expansion
  • Table 9.16: Compumedics Limited: Business Expansion and Recognition
  • Table 9.17: Compumedics Limited: Agreement
  • Table 9.18: Halma Plc: Acquisition
  • Table 9.19: Halma Plc: Certification, Product Development, and Product Approval
  • Table 9.20: Hill-Rom Holdings, Inc.: Acquisition and Agreement
  • Table 9.21: Hill-Rom Holdings, Inc.: Business Expansion and Product Approval
  • Table 9.22: iRhythm Technologies, Inc.: Recognition and Product Approval
  • Table 9.23: Meditech Ltd.: Acquisition and Agreement
  • Table 9.24: Micrel Medical Devices SA: Recognition
  • Table 9.25: Natus Medical Incorporated: Acquisitions
  • Table 9.26: Natus Medical Incorporated: Product Approval
  • Table 9.27: OSI Systems, Inc.: Agreement
  • Table 9.28: Smiths Group plc: Product Launch
  • Table 9.29: Smiths Group plc: Product Approval
  • Table 9.30: Vaso Corporation: Agreement
  • Table 9.31: Vaso Corporation: Business Expansion

List of Figures

  • Figure 1: Global Ambulatory Device Market Snapshot
  • Figure 2: Impact of Market Drivers and Market Restraints
  • Figure 3: Market Statistics
  • Figure 4: Global Ambulatory Device Market (by Product), $Billion
  • Figure 5: Global Ambulatory Device Market (by Product), 2017 and 2028
  • Figure 6: Global Ambulatory Device Market (by Application), 2017 and 2028
  • Figure 7: Global Ambulatory Device Market (by End User), 2017 and 2028
  • Figure 8: Global Ambulatory Device Market (by Region), 2017 and 2028
  • Figure 9: Global Ambulatory Device Market (by Region), 2017 and 2028
  • Figure 1.1: Classification of Ambulatory Devices
  • Figure 1.2: Advantages of Ambulatory Devices
  • Figure 1.3: Technological Trends in Ambulatory Devices
  • Figure 1.4: Ambulatory Devices: Areas of Interest
  • Figure 1.5: Ambulatory Devices: Future Potential
  • Figure 1.6: Global Ambulatory Device Market, 2017-2028
  • Figure 2.1: Market Dynamics of Global Ambulatory Device Market
  • Figure 3.1: Competitive Landscape, January 2014-May 2018
  • Figure 3.2: Share of Key Developments and Strategies, January 2014-May 2018
  • Figure 3.3: Product Launch Share (by Companies), January 2014-May 2018
  • Figure 3.4: Joint Ventures, Partnerships, and Collaborations Share (by Companies), January 2014-May 2018
  • Figure 3.5: Mergers and Acquisitions Share (by Companies), January 2014-May 2018
  • Figure 3.6: Market Share Analysis: Global Ambulatory Device Market
  • Figure 3.7: Porter's Five Forces Analysis
  • Figure 3.8: Bargaining Power of Suppliers: Overall Impact
  • Figure 3.9: Bargaining Power of Buyers: Overall Impact
  • Figure 3.10: Threat of New Entrant: Overall Impact
  • Figure 3.11: Threat of Substitute Products: Overall Impact
  • Figure 3.12: Intensity of Competitive Rivalry: Overall Impact
  • Figure 4.1: Industry Insights, January 2014-May 2018
  • Figure 4.2: Patent Share (by Assignee), January 2014-May 2018
  • Figure 5.1: Global Ambulatory Devices (by Products)
  • Figure 5.2: Global Ambulatory Device Market (by Products), 2017-2028
  • Figure 5.3: Global Ambulatory Device Market (by Monitoring Devices), 2017-2028
  • Figure 5.4: Global Ambulatory Device Market (by Infusion Systems), 2017-2028
  • Figure 5.5: Global Ambulatory Device Market (by Recorders), 2017-2028
  • Figure 5.6: Global Ambulatory Device Market (by Others), 2017-2028
  • Figure 6.1: Global Ambulatory Devices (by Applications)
  • Figure 6.2: Global Ambulatory Device Market (by Applications), 2017-2028
  • Figure 6.3: Global Ambulatory Device Market (by ECG Monitoring), 2017-2028
  • Figure 6.4: Global Ambulatory Device Market (by Drug Delivery), 2017-2028
  • Figure 6.5: Global Ambulatory Device Market (by Blood Pressure Monitoring), 2017-2028
  • Figure 6.6: Global Ambulatory Device Market (by Blood Glucose Monitoring), 2017-2028
  • Figure 6.7: Global Ambulatory Device Market (by EEG Monitoring), 2017-2028
  • Figure 6.8: Global Ambulatory Device Market (by Others), 2017-2028
  • Figure 7.1: Global Ambulatory Device Market (by End Users)
  • Figure 7.2: Global Ambulatory Device Market (by End Users), 2017-2028
  • Figure 7.3: Global Ambulatory Device Market (by Hospitals), 2017-2028
  • Figure 7.4: Global Ambulatory Device Market (by Ambulatory Surgical Centers and Outpatient Clinics), 2017-2028
  • Figure 7.5: Global Ambulatory Device Market (by Others), 2017-2028
  • Figure 8.1: Global Ambulatory Device Market Scenario, 2017 and 2028
  • Figure 8.2: North America: Ambulatory Device Market, 2017-2028
  • Figure 8.3: North America: Market Dynamics
  • Figure 8.4: North America: Ambulatory Device Market (by Country), 2017-2028
  • Figure 8.5: The U.S: Ambulatory Device Market, 2017-2028
  • Figure 8.6: Canada: Ambulatory Device market, 2017-2028
  • Figure 8.7: Europe: Ambulatory Device market, 2017-2028
  • Figure 8.8: Europe: Market Dynamics
  • Figure 8.9: Germany: Ambulatory Device Market, 2017-2028
  • Figure 8.10: France: Ambulatory Device market, 2017-2028
  • Figure 8.11: The U.K.: Ambulatory Device market, 2017-2028
  • Figure 8.12: Italy: Ambulatory Device market, 2017-2028
  • Figure 8.13: Spain: Ambulatory Device market, 2017-2028
  • Figure 8.14: The Netherlands: Ambulatory Device market, 2017-2028
  • Figure 8.15: Switzerland: Ambulatory Device market, 2017-2028
  • Figure 8.16: Belgium: Ambulatory Device market, 2017-2028
  • Figure 8.17: Sweden: Ambulatory Device market, 2017-2028
  • Figure 8.18: Austria: Ambulatory Device market, 2017-2028
  • Figure 8.19: Rest-of-Europe: Ambulatory Device market, 2017-2028
  • Figure 8.20: Asia-Pacific: Ambulatory Device market, 2017-2028
  • Figure 8.21: Asia-Pacific: Market Dynamics
  • Figure 8.22: Asia-Pacific: Ambulatory Device market (by Country), 2017-2028
  • Figure 8.23: Australia: Ambulatory Device market, 2017-2028
  • Figure 8.24: China: Ambulatory Device market, 2017-2028
  • Figure 8.25: India: Ambulatory Device market, 2017-2028
  • Figure 8.26: Japan: Ambulatory Device market, 2017-2028
  • Figure 8.27: South Korea: Ambulatory Device market, 2017-2028
  • Figure 8.28: Rest-of-Asia-Pacific: Ambulatory Device market, 2017-2028
  • Figure 8.29: Latin America: Ambulatory Device market, 2017-2028
  • Figure 8.30: Latin America: Market Dynamics
  • Figure 8.31: Latin America: Ambulatory Device market (by Country), 2017-2028
  • Figure 8.32: Brazil: Ambulatory Device market, 2017-2028
  • Figure 8.33: Mexico: Ambulatory Device market, 2017-2028
  • Figure 8.34: Argentina: Ambulatory Device market, 2017-2028
  • Figure 8.35: Rest-of-Latin America: Ambulatory Device market, 2017-2028
  • Figure 8.36: Middle East and Africa: Ambulatory Device market, 2017-2028
  • Figure 8.37: Middle East and Africa: Market Dynamics
  • Figure 8.38: Middle East and Africa: Ambulatory Device market (by Country), 2017-2028
  • Figure 8.39: South Africa: Ambulatory Device market, 2017-2028
  • Figure 8.40: Saudi Arabia: Ambulatory Device market, 2017-2028
  • Figure 8.41: U.A.E.: Ambulatory Device market, 2017-2028
  • Figure 8.42: Rest-of-Middle East and Africa: Ambulatory Device market, 2017-2028
  • Figure 8.43: Rest-of-the-World: Ambulatory Device market, 2017-2028
  • Figure 9.1: Shares of Key Company Profiles
  • Figure 9.2: Abbott Laboratories: Overall Product Portfolio
  • Figure 9.3: Abbott Laboratories: Product Portfolio for Ambulatory Device market
  • Figure 9.4: Abbott Laboratories: Overall Financials, 2015-2017
  • Figure 9.5: Abbott Laboratories: Revenue (by Business Segment), 2015-2017
  • Figure 9.6: Abbott Laboratories: Revenue (by Country), 2015-2017
  • Figure 9.7: Abbott Laboratories: Global Presence
  • Figure 9.8: SWOT Analysis: Abbott Laboratories
  • Figure 9.9: Baxter International Inc.: Overall Product Portfolio
  • Figure 9.10: Baxter International Inc.: Product Portfolio for Ambulatory Device market
  • Figure 9.11: Baxter International, Inc.: Overall Financials, 2015-2017
  • Figure 9.12: Baxter International, Inc.: Revenue (by Business Segment), 2015-2017
  • Figure 9.13: Baxter International, Inc.: Revenue (by Region), 2015-2017
  • Figure 9.14: Baxter International Inc.: Global Presence
  • Figure 9.15: Baxter International Inc. SWOT Analysis
  • Figure 9.16: Becton, Dickinson and Company: Overall Product Portfolio
  • Figure 9.17: Becton, Dickinson and Company: Product Portfolio for Ambulatory Device market
  • Figure 9.18: Becton, Dickinson and Company: Overall Financials, 2015-2017
  • Figure 9.19: Becton, Dickinson and Company: Revenue (by Business Segment), 2015-2017
  • Figure 9.20: Becton, Dickinson and Company: Revenue (by Business Sub-Segment), 2015-2017
  • Figure 9.21: Becton, Dickinson and Company: Revenue (by Region), 2015-2017
  • Figure 9.22: Becton, Dickinson and Company: Global Presence
  • Figure 9.23: Becton, Dickinson and Company: SWOT Analysis
  • Figure 9.24: BioTelemetry, Inc.: Overall Product Portfolio
  • Figure 9.25: BioTelemetry, Inc.: Product Portfolio for Ambulatory Device market
  • Figure 9.26: BioTelemetry, Inc.: Overall Financials, 2015-2017
  • Figure 9.27: BioTelemetry, Inc.: Revenue (by Business Segment), 2015-2017
  • Figure 9.28: BioTelemetry, Inc.: SWOT Analysis
  • Figure 9.29: Boston Scientific Corporation: Overall Product Portfolio
  • Figure 9.30: Boston Scientific Corporation: Product Portfolio for Ambulatory Device market
  • Figure 9.31: Boston Scientific Corporation: Overall Financials, 2015-2017
  • Figure 9.32: Boston Scientific Corporation: Revenue (by Business Segment), 2015-2017
  • Figure 9.33: Boston Scientific Corporation: Revenue (by Business Sub-Segment), 2015-2017
  • Figure 9.34: Boston Scientific Corporation: Revenue (by Region), 2015-2017
  • Figure 9.35: Boston Scientific Corporation: Global Presence
  • Figure 9.36: Boston Scientific Corporation: SWOT Analysis
  • Figure 9.37: Cadwell Industries, Inc.: Overall Product Portfolio
  • Figure 9.38: Cadwell Industries, Inc.: Product Portfolio for Ambulatory Device market
  • Figure 9.39: Cadwell Industries, Inc.: SWOT Analysis
  • Figure 9.40: CamNtech Ltd.: Overall Product Portfolio
  • Figure 9.41: CamNtech Ltd.: Product Portfolio for Global Ambulatory Device market
  • Figure 9.42: CamNtech Ltd.: SWOT Analysis
  • Figure 9.43: Cardiovascular Systems, Inc.: Overall Product Portfolio
  • Figure 9.44: Cardiovascular Systems, Inc.: Product Portfolio for Ambulatory Device market
  • Figure 9.45: Cardiovascular Systems, Inc.: Overall Financials, 2015-2017
  • Figure 9.46: Cardiovascular Systems, Inc.: SWOT Analysis
  • Figure 9.47: Compumedics Limited: Overall Product Portfolio
  • Figure 9.48: Compumedics Limited: Product Portfolio for Ambulatory Device market
  • Figure 9.49: Compumedics Limited: Overall Financials, 2015-2017
  • Figure 9.50: Compumedics Limited: Revenue (by Region), 2015-2017
  • Figure 9.51: Compumedics Limited: Global Presence
  • Figure 9.52: Compumedics Limited: SWOT Analysis
  • Figure 9.53: Dimetek Digital Medical Technologies, Ltd.: Overall Product Portfolio
  • Figure 9.54: Dimetek Digital Medical Technologies, Ltd.: Product Portfolio for Ambulatory Device market
  • Figure 9.55: Dimetek Digital Medical Technologies, Ltd.: SWOT Analysis
  • Figure 9.56: General Electric Company: Overall Product Portfolio
  • Figure 9.57: General Electric Company: Product Portfolio for Ambulatory Device market
  • Figure 9.58: General Electric Company: Overall Financials, 2015-2017
  • Figure 9.59: General Electric Company: Revenue (by Business Segment), 2015-2017
  • Figure 9.60: General Electric Company: Revenue (by Sub-Segment), 2016-2017
  • Figure 9.61: General Electric Company: Revenue (by Region), 2015-2017
  • Figure 9.62: General Electric Company: Healthcare Revenue (by Region), 2016-2017
  • Figure 9.63: General Electric Company: SWOT Analysis
  • Figure 9.64: Halma plc: Overall Product Portfolio
  • Figure 9.65: Halma plc: Product Portfolio for Ambulatory Device market
  • Figure 9.66: Halma plc: Overall Financials, 2016-2018
  • Figure 9.67: Halma plc: Revenue (by Business Segment), 2016-2018
  • Figure 9.68: Halma plc: Revenue (by Region), 2016-2018
  • Figure 9.69: Halma plc: Global Presence
  • Figure 9.70: Halma plc: SWOT Analysis
  • Figure 9.71: Hill-Rom Holdings, Inc.: Overall Product Portfolio
  • Figure 9.72: Hill-Rom Holdings, Inc.: Product Portfolio for Ambulatory Device market
  • Figure 9.73: Hill-Rom Holdings, Inc.: Overall Financials, 2014-2016
  • Figure 9.74: Hill-Rom Holdings, Inc.: Revenue (by Business Segment), 2015-2017
  • Figure 9.75: Hill-Rom Holdings, Inc.: Revenue (by Region), 2015-2017
  • Figure 9.76: Hill-Rom Holdings, Inc.: Global Presence
  • Figure 9.77: Hill-Rom Holdings, Inc.: SWOT Analysis
  • Figure 9.78: iRhythm Technologies, Inc.: Overall Product Portfolio
  • Figure 9.79: iRhythm Technologies, Inc.: Product Portfolio for Ambulatory Device market
  • Figure 9.80: iRhythm Technologies, Inc.: Overall Financials, 2015-2017
  • Figure 9.81: iRhythm Technologies, Inc.: Global Presence
  • Figure 9.82: SWOT Analysis: iRhythm Technologies, Inc.
  • Figure 9.83: Mediblu Medical LLC: Overall Product Portfolio
  • Figure 9.84: Mediblu Medical LLC: Product Portfolio for Ambulatory Device market
  • Figure 9.85: Mediblu Medical LLC: SWOT Analysis
  • Figure 9.86: Meditech Ltd.: Overall Product Portfolio
  • Figure 9.87: Meditech Ltd.: Product Portfolio for Ambulatory Device market
  • Figure 9.88: Meditech Ltd.: SWOT Analysis
  • Figure 9.89: Micrel Medical Devices SA: Overall Product Portfolio
  • Figure 9.90: Micrel Medical Devices SA: Product Portfolio for Ambulatory Device market
  • Figure 9.91: Micrel Medical Devices SA: SWOT Analysis
  • Figure 9.92: Natus Medical Incorporated: Overall Product Portfolio
  • Figure 9.93: Natus Medical Incorporated: Product Portfolio for Ambulatory Device market
  • Figure 9.94: Natus Medical Incorporated: Overall Financials, 2015-2017
  • Figure 9.95: Natus Medical Incorporated: Revenue (by Business Segment), 2015-2016
  • Figure 9.96: Natus Medical Incorporated: Revenue (by Business Segment), 2017 ($Million)
  • Figure 9.97: Natus Medical Incorporated: Revenue (by Business Sub-Segment), 2015-2017
  • Figure 9.98: Natus Medical Incorporated: Revenue (by Region), 2015-2017
  • Figure 9.99: Natus Medical Incorporated: Global Presence
  • Figure 9.100: Natus Medical Incorporated: SWOT Analysis
  • Figure 9.101: OSI Systems, Inc.: Overall Product Portfolio
  • Figure 9.102: Spacelabs Healthcare: Product Offerings for Ambulatory Device market
  • Figure 9.103: OSI Systems, Inc.: Overall Financials, 2015-2017
  • Figure 9.104: OSI Systems, Inc.: Revenue (by Business Segment), 2015-2017
  • Figure 9.105: OSI Systems, Inc.: Revenue (by Region), 2015-2017
  • Figure 9.106: OSI Systems, Inc.: Global Presence
  • Figure 9.107: OSI Systems, Inc.: SWOT Analysis
  • Figure 9.108: Siemens AG: Overall Product Portfolio
  • Figure 9.109: Siemens AG: Product Portfolio for Ambulatory Device market
  • Figure 9.110: Siemens AG: Overall Financials, 2015-2017
  • Figure 9.111: Siemens AG: Revenue (by Business Segment), 2015-2017
  • Figure 9.112: Siemens AG: Revenue (by Region), 2015-2017
  • Figure 9.113: Siemens AG: Global Presence
  • Figure 9.114: Siemens AG: SWOT Analysis
  • Figure 9.115: Smiths Group plc: Overall Product Portfolio
  • Figure 9.116: Smiths Group plc: Product Portfolio for Ambulatory Device market
  • Figure 9.117: Smiths Group plc: Overall Financials, 2015-2017
  • Figure 9.118: Smiths Group plc: Revenue (by Business Segment), 2015-2017
  • Figure 9.119: Smiths Group plc: Revenue (by Business Sub-division): Smiths Medical, 2015-2017
  • Figure 9.120: Smiths Group plc: Revenue (by Region), 2015-2016
  • Figure 9.121: Smiths Group plc: Global Presence
  • Figure 9.122: Smiths Group plc: SWOT Analysis
  • Figure 9.123: Vaso Corporation: Overall Product Portfolio
  • Figure 9.124: Vaso Corporation: Product Portfolio for Ambulatory Device market
  • Figure 9.125: Vaso Corporation: Overall Financials, 2015-2017
  • Figure 9.126: Vaso Corporation: Revenue (by Business Segment), 2015-2017
  • Figure 9.127: Vaso Corporation: Revenue (by Region), 2015-2017
  • Figure 9.128: Vaso Corporation: Global Presence
  • Figure 9.129: Vaso Corporation: SWOT Analysis
  • Figure 10.1: Global Ambulatory Device market Segmentation
  • Figure 10.2: Global Ambulatory Device market Segmentation
  • Figure 10.3: Primary Research
  • Figure 10.4: Secondary Research
  • Figure 10.5: Data Triangulation
  • Figure 10.6: Top-down Approach (Segment-wise Analysis)
  • Figure 10.7: Bottom-up Approach (Segment-wise Analysis)
  • Figure 10.8: Assumptions and Limitations
  • Figure 10.9: Considered Factors for Data Prediction and Modeling
Back to Top